ID: ALA3561646

Max Phase: Preclinical

Molecular Formula: C31H32F6N4O6

Molecular Weight: 442.56

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NCCN1CCC2(CC1)C(=O)NCN2Cc1ccccc1)c1ccc2ccccc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C27H30N4O2.2C2HF3O2/c32-25(24-11-10-22-8-4-5-9-23(22)18-24)28-14-17-30-15-12-27(13-16-30)26(33)29-20-31(27)19-21-6-2-1-3-7-21;2*3-2(4,5)1(6)7/h1-11,18H,12-17,19-20H2,(H,28,32)(H,29,33);2*(H,6,7)

Standard InChI Key:  KBNYLRLCCBUICU-UHFFFAOYSA-N

Associated Targets(Human)

Phospholipase D2 437 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Phospholipase D1 469 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 442.56Molecular Weight (Monoisotopic): 442.2369AlogP: 2.99#Rotatable Bonds: 6
Polar Surface Area: 64.68Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.88CX Basic pKa: 7.77CX LogP: 2.87CX LogD: 2.34
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.62Np Likeness Score: -0.89

References

1. PubChem BioAssay data set, 

Source

Source(1):